Parkinson's disease epidemiology and demographics
|
Parkinson's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parkinson's disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Parkinson's disease epidemiology and demographics |
|
Parkinson's disease epidemiology and demographics in the news |
|
Risk calculators and risk factors for Parkinson's disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
The incidence of parkinson disease is 8 to 18.6 per 100,000 person-years. The prevalence of Parkinson disease is about 0.3% in 40 years old people and older. According to this prevalence currently we have 7.5 million people affected by this disease. The prevalence of PD can rise with age. In 40 to 49 years old people the prevalence is 41 per 100,000 and in 80 years old and older people its 1900 per 100,000 people. Some studies suggest that men have a higher risk of developing Parkinson disease than women. In the study of Stephen K. Van Den Eeden and colleges it was suggested that the incidence of PD from higher to lower is in Hispanic, non-Hispanic whites and blacks.
Incidence
Prevalence
- The prevalence of Parkinson disease is about 0.3% in 40 years old people and older. According to this prevalence currently we have 7.5 million people affected by this disease.[2][3]
Age
- The prevalence of PD can rise with age. In 40 to 49 years old people the prevalence is 41 per 100,000 and in 80 years old and older people its 1900 per 100,000 people.[2]
Gender
- Some studies suggest that men have a higher risk of developing Parkinson disease than women.[1][2][4]
Race
- In the study of Stephen K. Van Den Eeden and colleges it was suggested that the incidence of PD from higher to lower is in Hispanic, non-Hispanic whites and blacks.[5]
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
References
- ↑ 1.0 1.1 de Lau LM, Breteler MM (June 2006). "Epidemiology of Parkinson's disease". Lancet Neurol. 5 (6): 525–35. doi:10.1016/S1474-4422(06)70471-9. PMID 16713924.
- ↑ 2.0 2.1 2.2 Pringsheim T, Jette N, Frolkis A, Steeves TD (November 2014). "The prevalence of Parkinson's disease: a systematic review and meta-analysis". Mov. Disord. 29 (13): 1583–90. doi:10.1002/mds.25945. PMID 24976103.
- ↑ Ross GW, Abbott RD (November 2014). "Living and dying with Parkinson's disease". Mov. Disord. 29 (13): 1571–3. doi:10.1002/mds.25955. PMID 25044188.
- ↑ Moisan F, Kab S, Mohamed F, Canonico M, Le Guern M, Quintin C, Carcaillon L, Nicolau J, Duport N, Singh-Manoux A, Boussac-Zarebska M, Elbaz A (September 2016). "Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis". J. Neurol. Neurosurg. Psychiatry. 87 (9): 952–7. doi:10.1136/jnnp-2015-312283. PMC 5013115. PMID 26701996.
- ↑ Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (June 2003). "Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity". Am. J. Epidemiol. 157 (11): 1015–22. PMID 12777365.